Tumor Lysis Syndrome

Tumor Lysis Syndrome is a topic covered in the Washington Manual of Medical Therapeutics.

To view the entire topic, please or purchase a subscription.

The Washington Manual of Medical Therapeutics helps you diagnose and treat hundreds of medical conditions. Consult clinical recommendations from a resource that has been trusted on the wards for 50+ years. Explore these free sample topics:

Washington Manual

-- The first section of this topic is shown below --

  • TLS is a group of metabolic disturbances resulting from significant tumor breakdown with release of intracellular products into circulation.
  • TLS occurs in tumors that grow rapidly and are sensitive to cytotoxic chemotherapy. The risk of TLS is high in patients with acute leukemias and high-grade lymphomas, bulky tumors, elevated pretreatment LDH and uric acid levels, and renal dysfunction.
  • TLS can also be spontaneous (not treatment related).
  • Certain medications such as venetoclax are associated with the development of TLS at treatment and warrant close surveillance.

-- To view the remaining sections of this topic, please or purchase a subscription --